Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Vaccine|June 22, 2010
Development and immunogenicity of a recombinant pseudorabies virus expressing Sj26GST and SjFABP from Schistosoma japonicumFeng Wei, Yujia Zhai, Hongtao Jin, et al.
Histopathology|December 4, 2024
Adenocarcinoma of the rete testis: clinicopathological study of 18 cases with emphasis on MET amplification and a review of the literatureYa Chen, Yanjun Chen, Qi Sun, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Fraxinellone Induces Hepatotoxicity in Zebrafish through Oxidative Stress and the Transporters PathwayShuting Wang, Jie Bao, Jie Li, et al.
Frontiers in Oncology|June 9, 2020
CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α PathwayYixiang Zhang, Yingduan Cheng, Zhaoxia Zhang, et al.
Central-European Journal of Immunology|July 7, 2025
Aberrant glucose metabolism drives dysfunction of CD4+ T cells in systemic lupus erythematosus and disease flaresLu Jin, Meng Ding, Shaoxin Cui, et al.
Lupus Science & Medicine|February 13, 2024
Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balanceMeng Ding, Lu Jin, Jinwen Zhao, et al.
Immunity, Inflammation and Disease|August 13, 2025
Human Umbilical Cord Mesenchymal Stem Cells Modulate Cytokine Secretion of CD4+ T Cell in Systemic Lupus Erythematosus by Inhibiting HSP90AA1 in the Glucose-Activated PI3K-AKT PathwayLu Jin, Meng Ding, Shaoxin Cui, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 25, 2026
Effect of ivarmacitinib on swelling and tenderness in small and large joints and imaging changes in patients with moderate-to-severe RA: a post hoc analysis of a phase III clinical trialYuxiang Han, Meng Ding, Shaoxin Cui, et al.
FEBS Open Bio|April 16, 2019
CFTR interacts with Hsp90 and regulates the phosphorylation of AKT and ERK1/2 in colorectal cancer cellsKaisheng Liu, Hongtao Jin, Yaomin Guo, et al.
Cell Biology International|April 9, 2019
JQ1, a BET-bromodomain inhibitor, inhibits human cancer growth and suppresses PD-L1 expressionKaisheng Liu, Zhifan Zhou, Hengyuan Gao, et al.
Pageof 11